Alectinib may block complement receptor 3 (CR3, encoded by ITGAM/CD11b) function on microglia, reducing recognition and engulfment of C1q-opsonized synapses without directly binding C1q. Genetic loss-of-function studies in mice demonstrate that both C1qa-/- and Itgam-/- impair postinjury debris clearance, establishing a functional C1q-CR3 axis (PMID: 29941548). Pharmacologic CR3 blockade reduces phagocytic microglia and early synapse loss, consistent with CR3 involvement in complement-mediated s
**Background and Rationale**
Alzheimer's disease (AD) pathogenesis is intimately linked to apolipoprotein E (APOE) isoform-dependent differences in amyloid-beta (Aβ) clearance and lipid metabolism. The APOE4 allele, present in approximately 25% of the population and 65% of AD patients, confers the highest genetic risk for late-onset AD. Unlike APOE2 and APOE3, APOE4 exhibits significantly reduced lipidation capacity and impaired Aβ clearance efficiency. This stems from structural differences in
Verdict Summary
7/10
dimensions won
ITGAM/CD11b direct binding explains micr
3/10
dimensions won
miR-33 Antisense Oligonucleotide Hyper-L
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.66
0.70
Evidence
0.62
0.75
Novelty
0.68
0.70
Feasibility
0.74
0.51
Impact
0.68
0.65
Druggability
0.56
0.55
Safety
0.55
0.45
Competition
0.58
0.50
Data
0.72
0.70
Reproducible
0.66
0.65
Score Breakdown
Dimension
ITGAM/CD11b direct binding exp
miR-33 Antisense Oligonucleoti
Mechanistic
0.660
0.700
Evidence
0.620
0.750
Novelty
0.680
0.700
Feasibility
0.740
0.510
Impact
0.680
0.650
Druggability
0.560
0.550
Safety
0.550
0.450
Competition
0.580
0.500
Data
0.720
0.700
Reproducible
0.660
0.650
Evidence
ITGAM/CD11b direct binding explains microglial phagocytosis
ITGAM/CD11b direct binding explains microglial pha
4 rounds · quality: 0.50
Theorist
1. **Glyco-C1q Lectin Bridging**
**Mechanism:** C1q binds directly to disease-altered N-glycans or O-glycans on myelin debris, apoptotic neurites, or synaptic membranes, while a separate C1q domain e...
Skeptic
# Critical Evaluation of C1q-Related Hypotheses
## Hypothesis 1: Glyco-C1q Lectin Bridging
### 1. Strongest Specific Weakness: Unfounded Dual-Domain Assumption
The hypothesis requires C1q to poss...
Domain Expert
# Domain Expert Evaluation: C1q-Related Hypotheses in Alzheimer's Disease
## Executive Summary
The Skeptic's fundamental challenge is well-founded: pursuing mechanistic studies on unvalidated prem...